PERSPECTIVE THERAPEUTICS INC (CATX)

Company Profile

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company is headquartered in Seattle, Washington and currently employs 88 full-time employees. The company went IPO on 2002-05-31. The firm is focused on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies, so its targeted medical doses are delivered directly to the tumor site. The Company’s core product is its Cesium-131 sealed source brachytherapy seed. These seeds can be inserted individually or in combination into various locations in the body. The firm also sells seeds in strands to keep them from individually moving. The Company’s segments are Brachytherapy and Drug Operations. Brachytherapy includes sales and manufacturing of Cesium-131 brachytherapy seeds, including research and development of new applications for the seeds. Drug Operations includes research and development and clinical operations related to the use of Lead-203 and Lead-212 as a diagnostic and a therapeutic drug.

Company Info

PERSPECTIVE THERAPEUTICS INC

2401 Elliott Avenue, Suite 320

Seattle WASHINGTON

P: 15093751202.0

Employees: 88

Website: https://isoray.com/